A compound’s toxicity can be gauged from the toxicities of the compounds it resembles. We showed that in 2003 for rat oral LD50: the compounds in a reference set of 13,645 that most resemble the query form a consortium and vote on its toxicity1. This work returns to that method twenty-three years later, on public data,...
Steven M. Muskal, Sanjiv K. Jha, Phani Kishore et al.· bioRxiv· 0 citations
This work predicted percent human intestinal absorption for 86 drug and drug-like compounds from six molecular descriptors chosen by a genetic algorithm and a small neural network and applied the same six descriptors, unchanged, to a larger set of 780 absorption measurements from a public compilation.
Steven M. Muskal, Matthew D. Wessel· bioRxiv· 0 citations
Biopharmaceutical companies routinely use forward screening to identify potential ligands for argets of biological consequence. Increasingly, they are also using reverse screening to proactively identify downstream off-target liabilities and new repurposing opportunities. Exhaustive reverse docking of one or a multitud...
Steven M. Muskal, G. Nicola· bioRxiv· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.